The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities

References

• Pavlou MP, Diamandis EP, Blasutig IM. The long journey of cancer biomarkers from the bench to the clinic. Clin Chem. 2013;59:147–157. DOI:10.1373/clinchem.2012.184614
   PubMed Web of Science ®Google Scholar
• Byron SA, Van Keuren-Jensen KR, Engelthaler DM, et al. Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat Rev Genet. 2016;17:257–271. DOI:10.1038/nrg.2016.10
   PubMed Web of Science ®Google Scholar
• Gordon BL, Finnerty BM, Aronova A, et al. Genomic medicine for cancer diagnosis. J Surg Oncol. 2015;111:24–30.
   PubMed Web of Science ®Google Scholar
• Stephens PJ, Greenman CD, Fu B, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011;144:27–40.
   PubMed Web of Science ®Google Scholar
• Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients : quantitations and evidence for their origin from apoptotic and necrotic cells DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necr. Cancer Res. 2001;61:1659–1665.
   PubMed Web of Science ®Google Scholar
• Diehl F, Li M, Dressman D, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci. 2005;102:16368–16373.
   PubMed Web of Science ®Google Scholar
• Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2013;489:57–74.
   Web of Science ®Google Scholar
• Stroun M, Anker P, Belianski M, et al. Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res. 1978;38:3546–3554. Available from: http://cancerres.aacrjournals.org/content/38/10/3546.long
   PubMed Web of Science ®Google Scholar
• Lo KW, Lo YMD, Leung SF, et al. Analysis of cell-free Epstein-Barr virus-associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem. 1999;45:1292–1294. Available from: http://clinchem.aaccjnls.org/content/clinchem/45/8/1292.full.pdf
   PubMed Web of Science ®Google Scholar
• Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141:672–675.
   PubMed Web of Science ®Google Scholar
• Wu X, Brewer G. The regulation of mRNA stability in mammalian cells: 2.0. Gene. NIH Public Access. 2012;500:10–21.
   PubMed Web of Science ®Google Scholar
• Koczera P, Martin L, Marx G, et al. The ribonuclease a superfamily in humans: canonical RNases as the buttress of innate immunity. Int J Mol Sci. 2016;17. DOI:10.3390/ijms17081278
   Web of Science ®Google Scholar
• Hynle I, Meuffels M, Poznanski WJ. Determination of phosphodiesterase I activity in human blood serum. Clin Chem. 1975;2110:1383–1387. Available from: http://clinchem.aaccjnls.org/content/clinchem/21/10/1383.full.pdf
   Google Scholar
• Lüthje J, Ogilvie A. 5ʹ-Nucleotide phosphodiesterase isoenzymes in human serum: quantitative measurement and some biochemical properties. Clin Chim Acta. 1987;164:275–284. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3036404
   PubMed Web of Science ®Google Scholar
• Bryzgunova OE, Laktionov PP. Extracellular nucleic acids in urine: sources, structure, diagnostic potential. Acta Naturae. 2015;7:48–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26483959
   PubMed Web of Science ®Google Scholar
• Tsui NBY, Ng EKO, Lo YMMD. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem. 2002;48:1647–1653. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11468248
   PubMed Web of Science ®Google Scholar
• Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta Rev Cancer. 2007;1775:181–232. DOI:10.1016/j.bbcan.2006.10.001
   PubMed Web of Science ®Google Scholar
• Hasselmann DO, Rappl G, Tilgen W, et al. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem. 2001;47:1488–1489.
   PubMed Web of Science ®Google Scholar
• Crescitelli R, Lässer C, Szabó TG, et al. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles. 2013;2:1–10. DOI:10.3402/jev.v2i0.20677
   Google Scholar
• Gallo A, Tandon M, Alevizos I, et al. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012;7:e30679.
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA. 2011;108:5003–5008.
   PubMed Web of Science ®Google Scholar
• Wagner J, Riwanto M, Besler C, et al. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler Thromb Vasc Biol. 2013;33:1392–1400.
   PubMed Web of Science ®Google Scholar
• Huang W, Zhao M, Wei N, et al. Site-specific RNase A activity was dramatically reduced in serum from multiple types of cancer patients. PLoS One. 2014;9. DOI:10.1371/journal.pone.0096490
   Google Scholar
• Spencer JD, Schwaderer AL, Eichler T, et al. An endogenous ribonuclease inhibitor regulates the antimicrobial activity of ribonuclease 7 in the human urinary tract. Kidney Int. 2014;85:1179–1191.
   PubMed Web of Science ®Google Scholar
• Ohashi A, Murata A, Cho Y, et al. Analysis of the expression and localization of RNase and RNase inhibitor in blood cells and vascular endothelial cells involved in homeostasis in the vascular system. J Thromb Haemost. 2015;13:575.
   Web of Science ®Google Scholar
• Smyth T, Kullberg M, Malik N, et al. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release. 2015;199:145–155.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Nishikawa M, Shinotsuka H, et al. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013;165:77–84.
   PubMed Web of Science ®Google Scholar
• Marsh JB, Welty FK, Schaefer EJ. Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans. Curr Opin Lipidol. 2000;11:261–266.
   PubMed Web of Science ®Google Scholar
• Watts GF, Moroz P, Barrett PHR. Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies. Metabolism. 2000;49:1204–1210.
   PubMed Web of Science ®Google Scholar
• Poon IKH, Lucas CD, Rossi AG, et al. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol. 2014;14:166–180.
   PubMed Web of Science ®Google Scholar
• Javidi MA, Ahmadi AH, Bakhshinejad B, et al. Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids. Med Oncol. 2014;31:295.
   PubMed Web of Science ®Google Scholar
• Pellegrini KL, Sanda MG, Moreno CS. RNA biomarkers to facilitate the identification of aggressive prostate cancer. Mol Aspects Med. 2015;45:37–46.
   PubMed Web of Science ®Google Scholar
• Gallo A, Vukic D, Michalík D, et al. ADAR RNA editing in human disease; more to it than meets the I. Hum Genet. 2017;136:1265–1278.
   PubMed Web of Science ®Google Scholar
• Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012;13:358–369.
   PubMed Web of Science ®Google Scholar
• Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. DOI: 10.1038/nrg2934
   Google Scholar
• Modelska A, Quattrone A, Re A. Molecular portraits: the evolution of the concept of transcriptome-based cancer signatures. Brief Bioinform. 2015;16:1000–1007.
   PubMed Web of Science ®Google Scholar
• Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest. 2005;115:1503–1521.
   PubMed Web of Science ®Google Scholar
• Marisa L, de Reyniès A, Duval A, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. Public Library of Science. 2013;10:e1001453.
   PubMed Web of Science ®Google Scholar
• Brodtkorb M, Lingjærde OC, Huse K, et al. Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma. Blood. 2014;123:1051–1054.
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–838.
   PubMed Web of Science ®Google Scholar
• Søkilde R, Vincent M, Møller AK, et al. Efficient identification of miRNAs for classification of tumor origin. J Diagn. 2014;16:106–115. DOI:10.1016/j.jmoldx.2013.10.001
   PubMed Web of Science ®Google Scholar
• Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26:462–469.
   PubMed Web of Science ®Google Scholar
• Pease J, Kinross C. Improved RNA-seq of blood-derived RNA increases gene discovery and coverage. Nat Methods. 2013;10:i–ii.
   Google Scholar
• Shin H, Shannon CP, Fishbane N, et al. Variation in RNA-Seq transcriptome profiles of peripheral whole blood from healthy individuals with and without globin depletion. PLoS One. 2014;9. DOI:10.1371/journal.pone.0091041
   Web of Science ®Google Scholar
• Kaczkowski B, Tanaka Y, Kawaji H, et al. Transcriptome analysis of recurrently deregulated genes across multiple cancers identifies new pan-cancer biomarkers. Cancer Res. 2016;76:216–226.
   PubMed Web of Science ®Google Scholar
• Cann GM, Gulzar ZG, Cooper S, et al. mRNA-seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. PLoS One. 2012;7. DOI:10.1371/journal.pone.0049144
   Google Scholar
• Fernandez-Mercado M, Manterola L, Larrea E, et al. The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids. J Cell Mol Med. 2015;19. DOI:10.1111/jcmm.12625
   Web of Science ®Google Scholar
• Kishikawa T, Otsuka M, Ohno M, et al. Circulating RNAs as new biomarkers for detecting pancreatic cancer. World J Gastroenterol. 2015;21:8527–8540.
   PubMed Web of Science ®Google Scholar
• Cheng G. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy. Adv Drug Deliv Rev. 2015;81:75–93.
   PubMed Web of Science ®Google Scholar
• Previdi MC, Carotenuto P, Zito D, et al. Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know? Futur Oncol. Future Medicine Ltd London, UK. 2017;13:443–453.
   PubMed Web of Science ®Google Scholar
• Schou J, Johansen J, Nielsen D, et al. Circulating microRNAs as prognostic and predictive biomarkers in patients with colorectal cancer. Non-Coding RNA. 2016;2:5.
   Google Scholar
• Qiu X, Zhang J, Shi W, et al. Circulating microRNA-26a in plasma and its potential diagnostic value in gastric cancer. PLoS One. 2016;11. DOI:10.1371/journal.pone.0151345
   Google Scholar
• Larrea E, Sole C, Manterola L, et al. New concepts in cancer biomarkers: circulating miRNAs in liquid biopsies. Int J Mol Sci. 2016;17:627.
   PubMed Web of Science ®Google Scholar
• Wang W-T, Chen Y-Q. Circulating miRNAs in cancer: from detection to therapy. J Hematol Oncol. 2014;7:86.
   PubMed Web of Science ®Google Scholar
• He Y, Lin J, Kong D, et al. Current state of circulating microRNAs as cancer biomarkers. Clin Chem. 2015;61:1138–1155.
   PubMed Web of Science ®Google Scholar
• Qi P, Zhou X-Y DX. Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol Cancer. 2016;15:39.
   PubMed Web of Science ®Google Scholar
• Deng H, Wang JM, Li M, et al. Long non-coding RNAs: new biomarkers for prognosis and diagnosis of colon cancer. Tumor Biol. 2017;39:101042831770633.
   Google Scholar
• Shi T, Gao G, Cao Y. Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics. Dis Markers. 2016;2016. DOI:10.1155/2016/9085195
   Web of Science ®Google Scholar
• Bolha L, Ravnik-Glavač M, Glavač D. Long noncoding RNAs as biomarkers in cancer. Dis Markers. 2017;2017. DOI:10.1155/2017/7243968
   Web of Science ®Google Scholar
• Saus E, Brunet-Vega A, Iraola-Guzmán S, et al. Long non-coding RNAs as potential novel prognostic biomarkers in colorectal cancer. Front Genet. 2016;7. DOI:10.3389/fgene.2016.00054
   PubMed Web of Science ®Google Scholar
• Liang W, Lv T, Shi X, et al. Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer. Diagn Accuracy Study. 2016;1–7. DOI:10.1097/MD.0000000000004608
   Google Scholar
• Zhang K, Shi H, Xi H, et al. Genome-wide lncRNA microarray profiling identifies novel circulating lncrnas for detection of gastric cancer. Theranostics. 2017;7:213–227.
   PubMed Web of Science ®Google Scholar
• Chen S, Liang H, Yang H, et al. LincRNa-p21: function and mechanism in cancer. Med Oncol. 2017;34:98.
   PubMed Web of Science ®Google Scholar
• Assumpção CB, Calcagno DQ, Araújo TMT, et al. The role of piRNA and its potential clinical implications in cancer. Epigenomics. NIH Public Access. 2015;7:975–984.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Honda S, Kirino Y. PIWI expression and function in cancer. Front Genet. 2012;3. DOI:10.3389/fgene.2012.00204
   PubMedGoogle Scholar
• Liu Y. MicroRNAs and PIWI-interacting RNAs in oncology (Review). Oncol Lett. 2016;12:2289–2292.
   PubMed Web of Science ®Google Scholar
• Siddiqi S, Matushansky I. Piwis and piwi-interacting RNAs in the epigenetics of cancer. J Cell Biochem. 2012;113:373–380.
   PubMed Web of Science ®Google Scholar
• Kishikawa T, Otsuka M, Yoshikawa T, et al. Quantitation of circulating satellite RNAs in pancreatic cancer patients. JCI Insight. 2016;1:e86646.
   PubMed Web of Science ®Google Scholar
• Kishikawa T, Otsuka M, Yoshikawa T, et al. Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1. Nat Commun. 2016;7:13006.
   PubMed Web of Science ®Google Scholar
• Feng H, Qin Z, Zhang X. Opportunities and methods for studying alternative splicing in cancer with RNA-Seq. Cancer Lett. 2013;340:179–191.
   PubMed Web of Science ®Google Scholar
• Bösl A, Spitzmüller A, Jasarevic Z, et al. MammaPrint versus EndoPredict: poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer. PLoS One. 2017;12. DOI:10.1371/journal.pone.0183458
   Web of Science ®Google Scholar
• Nagayasu K, Komiyama H, Ishiyama S, et al. Investigation of free cancer cells in peripheral blood using CEA mRNA expression in perioperative colorectal cancer patients. Mol Clin Oncol. 2013;1:668–674.
   PubMedGoogle Scholar
• De Souza MF, Kuasne H, Barros-Filho M de C, et al. Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer. PLoS One. 2017;12:e0184094.
   PubMed Web of Science ®Google Scholar
• March-Villalba JA, Martínez-Jabaloyas JM, Herrero MJ, et al. Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristics. PLoS One. 2012;7. DOI:10.1371/journal.pone.0043470
   Google Scholar
• García V, García JM, Peña C, et al. Free circulating mRNA in plasma from breast cancer patients and clinical outcome. Cancer Lett. 2008;263:312–320.
   PubMed Web of Science ®Google Scholar
• Yuan T, Huang X, Woodcock M, et al. Plasma extracellular RNA profiles in healthy and cancer patients. Sci Rep. 2016;6:19413. DOI:10.1038/srep19413
   PubMed Web of Science ®Google Scholar
• Huang X, Yuan T, Tschannen M, et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics. 2013;14:319.
   PubMed Web of Science ®Google Scholar
• Lázaro-Ibáñez E, Lunavat TR, Jang SC, et al. Distinct prostate cancer-related mRNA cargo in extracellular vesicle subsets from prostate cell lines. BMC Cancer. 2017;17:92.
   PubMed Web of Science ®Google Scholar
• Nilsson J, Skog J, Nordstrand A, et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer. 2009;100:1603–1607.
   PubMed Web of Science ®Google Scholar
• Goldvaser H, Gutkin A, Beery E, et al. Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer marker. Br J Cancer. 2017;117:353–357.
   PubMed Web of Science ®Google Scholar
• Miguel Garcia J, Garcia V, Pena C, et al. Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched. RNA. 2008;14:1424–1432.
   PubMed Web of Science ®Google Scholar
• Lanzós A, Carlevaro-Fita J, Mularoni L, et al. Discovery of cancer driver long noncoding RNAs across 1112 tumour genomes: new candidates and distinguishing features. Sci Rep. 2017;7:41544.
   PubMed Web of Science ®Google Scholar
• Jin HY, Lai M, Xiao C. microRNA-17-92 is a powerful cancer driver and a therapeutic target. Cell Cycle. 2014;13:495–496.
   PubMed Web of Science ®Google Scholar
• Pon JR, Marra MA. Driver and passenger mutations in cancer. Annu Rev Pathol Mech Dis. 2015;10:25–50.
   PubMed Web of Science ®Google Scholar
• Danielson KM, Rubio R, Abderazzaq F, et al. High throughput sequencing of extracellular RNA from human plasma. Margis R, editor. PLoS One. 2017;12:e0164644.
   PubMed Web of Science ®Google Scholar
• Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002;99:15524–15529.
   PubMed Web of Science ®Google Scholar
• Munker R, Calin GA. MicroRNA profiling in cancer. Clin Sci. 2011;121:141–158.
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Calin GA, Lopez-Berestein G, et al. miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 2016;6:235–246.
   PubMed Web of Science ®Google Scholar
• Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56:1733–1741.
   PubMed Web of Science ®Google Scholar
• Russo F, Di Bella S, Vannini F, et al. miRandola 2017: a curated knowledge base of non-invasive biomarkers. Nucleic Acids Res. 2017. DOI:10.1093/nar/gkx854
   Google Scholar
• Sozzi G, Boeri M, Rossi M, et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol. 2014;32:768–773. DOI:10.1200/JCO.2013.50.4357
   PubMed Web of Science ®Google Scholar
• Montani F, Marzi MJ, Dezi F, et al. miR-Test: a blood test for lung cancer early detection. J Natl Cancer Inst. 2015;107:djv063.
   PubMedGoogle Scholar
• Sozzi G, Boeri M. Potential biomarkers for lung cancer screening. Transl Lung Cancer Res. 2014;3:139–148.
   PubMedGoogle Scholar
• Ponnusamy M, Yan KW, Liu CY, et al. PIWI family emerging as a decisive factor of cell fate: an overview. Eur J Cell Biol. 2017;96:746–757.
   PubMed Web of Science ®Google Scholar
• Ng KW, Anderson C, Marshall EA, et al. Piwi-interacting RNAs in cancer: emerging functions and clinical utility. Mol Cancer. 2016;15:5.
   PubMed Web of Science ®Google Scholar
• Martinez VD, Vucic EA, Thu KL, et al. Unique somatic and malignant expression patterns implicate PIWI-interacting RNAs in cancer-type specific biology. Sci Rep. 2015;5. DOI:10.1038/srep10423
   Web of Science ®Google Scholar
• Stepanov GA, Filippova JA, Komissarov AB, et al. Regulatory role of small nucleolar RNAs in human diseases. Biomed Res Int. 2015;2015:1–10.
   Web of Science ®Google Scholar
• Thorenoor N, Slaby O. Small nucleolar RNAs functioning and potential roles in cancer. Tumor Biol. 2015;36:41–53.
   PubMedGoogle Scholar
• Mannoor K, Liao J, Jiang F. Small nucleolar RNAs in cancer. DOI: 10.1016/j.bbcan.2012.03.005
   Google Scholar
• Köhler J, Schuler M, Gauler TC, et al. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients. J Cancer Res Clin Oncol. 2016;142:795–805.
   PubMed Web of Science ®Google Scholar
• Kuhlmann JD, Baraniskin A, Hahn SA, et al. Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancer. Clin Chem. 2014;60:206–213.
   PubMed Web of Science ®Google Scholar
• Baraniskin A, Nöpel-Dünnebacke S, Ahrens M, et al. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma. Int J Cancer. 2013;132:E48–E57.
   PubMed Web of Science ®Google Scholar
• Su J, Liao J, Gao L, et al. Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis. Oncotarget. 2015;7. Available from: www.impactjournals.com/oncotarget
   Web of Science ®Google Scholar
• Liao J, Yu L, Mei Y, et al. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer. 2010;9:198.
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–159.
   PubMed Web of Science ®Google Scholar
• Marchese FP, Huarte M. Long non-coding RNAs and chromatin modifiers: their place in the epigenetic code. Epigenetics. 2014;9:21–26.
   PubMed Web of Science ®Google Scholar
• Khalil AM, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci. 2009;106:11667–11672.
   PubMed Web of Science ®Google Scholar
• Prensner JR, Iyer MK, Sahu A, et al. The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet. 2013;45:1392–1403.
   PubMed Web of Science ®Google Scholar
• Wang KC, Yang YW, Liu B, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011;472:120–126.
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21. DOI:10.1038/nm.3981
   Web of Science ®Google Scholar
• Liz J, Esteller M. lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta Gene Regul Mech. 2016;1859:169–176.
   PubMed Web of Science ®Google Scholar
• Deniz E, Erman B. Long noncoding RNA (lincRNA), a new paradigm in gene expression control. Funct Integr Genomics. 2017;17:135–143.
   PubMed Web of Science ®Google Scholar
• Kartha RV, Subramanian S. Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation. Front Genet. 2014;5:1–9.
   PubMed Web of Science ®Google Scholar
• Weber DG, Johnen G, Casjens S, et al. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res Notes. 2013;6:518.
   PubMedGoogle Scholar
• Isin M, Ozgur E, Cetin G, et al. Investigation of circulating lncRNAs in B-cell neoplasms. Clin Chim Acta. 2014;431:255–259.
   PubMed Web of Science ®Google Scholar
• Fayda M, Isin M, Tambas M, et al. Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy? Tumor Biol. 2016;37:3969–3978.
   PubMedGoogle Scholar
• Tang H, Wu Z, Zhang J, et al. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep. 2013;7:761–766.
   PubMed Web of Science ®Google Scholar
• Rivas A, Burzio V, Landerer E, et al. Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer. BMC Urol. 2012;12:1.
   PubMed Web of Science ®Google Scholar
• Leyten GHJM, Hessels D, Jannink SA, et al. Platinum priority – prostate cancer prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer. Eur Urol. 2014;65:534–542.
   PubMed Web of Science ®Google Scholar
• McKiernan J, Donovan MJ, O’Neill V, et al. A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy. JAMA Oncol. 2016;2:882–889.
   PubMed Web of Science ®Google Scholar
• Boeri M, Verri C, Conte D, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci. 2011;108:3713–3718.
   PubMed Web of Science ®Google Scholar
• Durand X, Moutereau S, Xylinas E. et al. ProgensaTM PCA3 test for prostate cancer. Expert Rev Mol Diagn. 2011;11:137–144.
   PubMed Web of Science ®Google Scholar
• Cornu J-N, Cancel-Tassin G, Egrot C, et al. Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer. Prostate. 2013;73:242–249.
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333–338.
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384–388.
   PubMed Web of Science ®Google Scholar
• Du WW, Fang L, Yang W, et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 2016;24:357–370.
   PubMed Web of Science ®Google Scholar
• Rong D, Sun H, Li Z, et al. An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget. 2017. DOI:10.18632/oncotarget.19154
   Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Venø MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2017. DOI:10.1038/onc.2017.361
   PubMed Web of Science ®Google Scholar
• Yang W, Du WW, Li X, et al. Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesis. Oncogene. 2016;35:3919–3931.
   PubMed Web of Science ®Google Scholar
• Wang F, Nazarali AJ, Ji S. Circular RNAs as potential biomarkers for cancer diagnosis and therapy. Am J Cancer Res. 2016 [ e-Century Publishing Corporation];6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27429839
   Web of Science ®Google Scholar
• Memczak S, Papavasileiou P, Peters O, et al. Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood. PLoS One. 2015;10:1–13.
   Google Scholar
• Huang M, Huang Q, He Y-R, et al. Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer. World J Gastroenterol. 2017;23:6330.
   Web of Science ®Google Scholar
• Li P, Chen S, Chen H, et al. Using circular RNA as a novel type of biomarker in the screening of gastric cancer. Clin Chim Acta. 2015;444:132–136.
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25:981–984.
   PubMed Web of Science ®Google Scholar
• Balatti V, Nigita G, Veneziano D, et al. tsRNA signatures in cancer. Proc Natl Acad Sci. 2017;114:8071–8076.
   PubMed Web of Science ®Google Scholar
• Pekarsky Y, Balatti V, Palamarchuk A, et al. Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer. Proc Natl Acad Sci. 2016;113:5071–5076.
   PubMed Web of Science ®Google Scholar
• Guo Y, Bosompem A, Mohan S, et al. Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes. BMC Genomics. 2015;16:727.
   PubMed Web of Science ®Google Scholar
• Sun C, Fu Z, Wang S, et al. Roles of tRNA-derived fragments in human cancers. Cancer Lett. 2018;414:16–25.
   PubMed Web of Science ®Google Scholar
• Tolkach Y, Stahl AF, Niehoff EM, et al. YRNA expression predicts survival in bladder cancer patients. BMC Cancer. 2017;17. DOI:10.1186/s12885-017-3746-y
   PubMedGoogle Scholar
• Nientiedt M, Schmidt D, Kristiansen G, et al. YRNA expression profiles are altered in clear cell renal cell carcinoma. Eur Urol Focus. 2016. DOI:10.1016/j.euf.2016.08.004
   PubMedGoogle Scholar
• Dhahbi SS, Atamna H, Boffelli D, et al. Deep sequencing of serum small RNAs identifies patterns of 5’ tRNA half and YRNA fragment expression associated with breast cancer. Biomark Cancer. 2014;37. DOI:10.4137/BIC.S20764
   PubMedGoogle Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell. 2011;146:353–358.
   PubMed Web of Science ®Google Scholar
• Witwer KW. Circulating microRNA biomarker studies: pitfalls and potential solutions. Clin Chem. 2015;61:56–63.
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19:141–157.
   PubMed Web of Science ®Google Scholar
• Sourvinou IS, Markou A, Lianidou ES. Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability. J Diagn. 2013;15:827–834.
   PubMed Web of Science ®Google Scholar
• Glinge C, Clauss S, Boddum K, et al. Stability of circulating blood-based microRNAs – pre-analytic methodological considerations. PLoS One. 2017;12:e0167969.
   Web of Science ®Google Scholar
• Beatty M, Guduric-Fuchs J, Brown E, et al. Small RNAs from plants, bacteria and fungi within the order Hypocreales are ubiquitous in human plasma. BMC Genomics. 2014;15:933.
   PubMed Web of Science ®Google Scholar
• Moldovan L, Batte KE, Trgovcich J, et al. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med. 2014;18:371–390.
   PubMed Web of Science ®Google Scholar
• Witwer KW, Buzás EI, Bemis LT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2:20360.
   PubMedGoogle Scholar
• Kingston RE. Preparation and analysis of RNA. Curr Protoc Mol Biol. 2010. DOI:10.1002/0471142727.mb0400s58
   Google Scholar
• Moret I, Sańchez-Izquierdo D, Borra M, et al. Assessing an improved protocol for plasma microRNA extraction. PLoS One. 2013;8:1–10.
   Web of Science ®Google Scholar
• Brunet-Vega A, Pericay C, Quílez ME, et al. Variability in microRNA recovery from plasma: comparison of five commercial kits. Anal Biochem. 2015;488:28–35.
   PubMed Web of Science ®Google Scholar
• Page K, Guttery DS, Zahra N, et al. Influence of plasma processing on recovery and analysis of circulating nucleic acids. PLoS One. 2013;8:2–11.
   Web of Science ®Google Scholar
• Kim YK, Yeo J, Kim B, et al. Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells. Mol Cell. 2012;46:893–895. DOI:10.1016/j.molcel.2012.05.036
   PubMed Web of Science ®Google Scholar
• Rapisuwon S, Vietsch EE, Wellstein A. Circulating biomarkers to monitor cancer progression and treatment. Comput Struct Biotechnol J. 2016;14:211–222.
   PubMed Web of Science ®Google Scholar
• Mestdagh P, Hartmann N, Baeriswyl L, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 2014;11:809–815.
   PubMed Web of Science ®Google Scholar
• Diamandis EP. The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem? . BioMed Cent. 2012;10:87.
   Google Scholar
• Pritchard CC, Kroh E, Wood B, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila). 2012;5:492–497.
   PubMed Web of Science ®Google Scholar
• Parkinson DR, McCormack RT, Keating SM, et al. Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer. Clin Cancer Res. 2014;20:1428–1444.
   PubMed Web of Science ®Google Scholar
• Quinn JF, Patel T, Wong D, et al. Extracellular RNAs: development as biomarkers of human disease. J Extracell Vesicles. 2015;4. DOI:10.3402/jev.v4.27495
   Web of Science ®Google Scholar
• Majewski IJ, Bernards R. Taming the dragon: genomic biomarkers to individualize the treatment of cancer. Nat Med. 2011;304–312. DOI:10.1038/nm.2311
   PubMed Web of Science ®Google Scholar
• Grossman RL, Abel B, Angiuoli S, et al. Collaborating to compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium [Internet]. Clin Pharmacol Ther. 2017;101:589–592.
   PubMed Web of Science ®Google Scholar
• Ainsztein AM, Brooks PJ, Dugan VG, et al. The NIH Extracellular RNA Communication Consortium. J Extracell Vesicles. 2015;4. DOI:10.3402/jev.v4.27493
   Web of Science ®Google Scholar